TY - JOUR
T1 - Proteomic identification of specific glycosyltransferases functionally implicated for the biosynthesis of a targeted glyco-epitope
AU - Lin, Chi Hung
AU - Lin, Chia Wei
AU - Khoo, Kay Hooi
PY - 2008/2
Y1 - 2008/2
N2 - Functional glycomic and glycoproteomic analyses often entail correlating the mapped glycosylation pattern of a cell against the activities of specific glycosyltransferases it expresses. While the mRNA transcripts can be readily mapped, the expression of a functional glycosyltransferase at protein level has defied most current proteomic approaches. To enable identification of these low abundant Golgi residing membrane bound proteins, we have developed a novel semigel-based shotgun proteomic workflow incorporating subcellular fractionation and one-step affinity enrichment of the detergent solubilized Golgi preparation on resins derivatized with nucleotide diphosphates. Applying the strategy to a colonic adenocarcinoma, Colo205, which is known to aberrantly synthesize abundant fucosylated extended type 1 chain, we first validated that β3-galactosyltransferase 5 (β3GalT5) is indeed the overexpressed β3GalT. This and β4GalT1 are the two galactosyltrasferases which were positively identified by proteomic analysis of the eluted fractions from uridine diphosphate (UDP)-affinity column. Substituting UDP with a guanidine diphosphate (GDP)-affinity column and monitoring the eluted fractions for enriched α3/4-fucosyltransferase (FucT) activities, we then identified FucT3 and FucT6 as the two major α3/4FucTs expressed in Colo205 at the protein level. Our proteomic analysis demonstrated that not all GDP-utilizing glycosyltransferases bind and are retained similarly by the GDP-affinity column and that specific activity assay along with optimization of binding and elution conditions is critical for successful identification of a particular subset of the targeted glycosyltransferases. Only OFUT1, a protein O-FucT, was additionally identified to coelute with the α3/4FucT activity, and not other GDP-fucose utilizing FucTs.
AB - Functional glycomic and glycoproteomic analyses often entail correlating the mapped glycosylation pattern of a cell against the activities of specific glycosyltransferases it expresses. While the mRNA transcripts can be readily mapped, the expression of a functional glycosyltransferase at protein level has defied most current proteomic approaches. To enable identification of these low abundant Golgi residing membrane bound proteins, we have developed a novel semigel-based shotgun proteomic workflow incorporating subcellular fractionation and one-step affinity enrichment of the detergent solubilized Golgi preparation on resins derivatized with nucleotide diphosphates. Applying the strategy to a colonic adenocarcinoma, Colo205, which is known to aberrantly synthesize abundant fucosylated extended type 1 chain, we first validated that β3-galactosyltransferase 5 (β3GalT5) is indeed the overexpressed β3GalT. This and β4GalT1 are the two galactosyltrasferases which were positively identified by proteomic analysis of the eluted fractions from uridine diphosphate (UDP)-affinity column. Substituting UDP with a guanidine diphosphate (GDP)-affinity column and monitoring the eluted fractions for enriched α3/4-fucosyltransferase (FucT) activities, we then identified FucT3 and FucT6 as the two major α3/4FucTs expressed in Colo205 at the protein level. Our proteomic analysis demonstrated that not all GDP-utilizing glycosyltransferases bind and are retained similarly by the GDP-affinity column and that specific activity assay along with optimization of binding and elution conditions is critical for successful identification of a particular subset of the targeted glycosyltransferases. Only OFUT1, a protein O-FucT, was additionally identified to coelute with the α3/4FucT activity, and not other GDP-fucose utilizing FucTs.
KW - Affinity capture
KW - Glycosyltransferases
KW - Subcellular fractionation
UR - http://www.scopus.com/inward/record.url?scp=39149091075&partnerID=8YFLogxK
U2 - 10.1002/pmic.200700710
DO - 10.1002/pmic.200700710
M3 - Article
C2 - 18186023
AN - SCOPUS:39149091075
VL - 8
SP - 475
EP - 483
JO - Proteomics
JF - Proteomics
SN - 1615-9853
IS - 3
ER -